Relation between consumption of Progesterone and pregnancy in the IUI cycle

The relationship between consumption of Progesterone suppository and pregnancy rate in intrauterine insemination (IUI) method

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180602039952N1

Enrollment

Registered

2018-06-05

Start date

2018-06-21

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: Individuals within the IUI cycles receive twice daily 400 mg progesterone suppositories. Intervention 2: Control group: The control group will receive the usual tre

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertility duration <10 years BMI index less than 27 Kg / m2 Normal hormonal tests and hysterosalpingography (at least one patent tube)

Exclusion criteria

Exclusion criteria: Male infertility (moderate to severe oligospermia) Bilateral obstruction of fallopian tubes in hysterosalpingography Ovarian hyperstimulation Very poor ovarian reserve Coexisting uterine anomalies The presence of uterine tube obstruction

Design outcomes

Primary

Measure	Time frame
Pregnancy: A condition in which a pregnant woman keeps her growing fetus before delivery in her body, from fertilization to birth. In this study it will determine according to the diagnosis based on the positive results of the ß-HCG test. Timepoint: Immediately after the end of treatment in two groups. Method of measurement: By the ß-HCG test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Farzaneh

Zahedan University of Medical Sciences

f.farzaneh@zaums.ac.ir+98 54 3329 5744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026